Pharmafile Logo

Peter Impey

- PMLiVE

Eisai takes control of weight loss drug Belviq from Arena

Buys global rights to obesity drug in $49m deal to expedite roll-out and boost sales

- PMLiVE

Greece steps up Novartis corruption probe after suicide attempt

Accelerates investigation into whether Novartis paid bribes to doctors and civil servants to drive sales

How can pharma help the NHS drive much-needed change in mental health services?

Laurence Mascarenhas, of Wilmington Healthcare, assesses how pharma can help the NHS to achieve Parity of Esteem (PoE) in mental health

Wilmington Healthcare

- PMLiVE

The EarthWorks: New ways to improve patient care

How marketing efforts in the pharma industry can improve outcomes while delivering increased value to healthcare providers and payers

Eric Cornut appointed EFPIA interim director general

Steps into the role as Richard Bergström leaves the association

Actinium appoints director of clinical operations

Gregory Bergonio brings experience from Novartis

- PMLiVE

Sanofi and Merck & Co finalise vaccine alliance split

Dissolve Sanofi Pasteur MSD after poor sales growth

- PMLiVE

Sanofi and Boehringer Ingelheim complete €21.8bn asset swap

Exchange of animal health and consumer interests sharpens the firm's focus

Sanofi reception

Sanofi launches insulin combo Soliqua in US

Diabetes drug available in pharmacies for $127 per 300 unit pen ahead of Novo Nordisk's Xultophy

Bayer symbol

Bayer nets speedy US review for regorafenib in liver cancer

Priority review in HCC boosts hopes for rejuvenation of Stivarga to combat declining sales

- PMLiVE

NOR-SWITCH – the final piece in the biosimilar puzzle?

As more biosimilars become available globally, physicians, payers and patients alike are keen to understand the safety of switching

- PMLiVE

Robocath appoints CEO

Pascal Guy promoted at medical robotics start-up

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links